Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Is TB-500 Legal In The US?

TB-500 is legal in the US when prescribed by a licensed physician and dispensed by a compounding pharmacy. It is not a controlled substance under federal law.

Reviewed by Form Blends Medical Team|Updated March 2026

Is TB-500 Legal In The US?

Yes, TB-500 is legal in the United States when obtained through a licensed physician's prescription and dispensed by a regulated compounding pharmacy. It is not classified as a controlled substance under federal law.

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide found in nearly all human and animal cells. As a peptide compound, TB-500 occupies a specific regulatory space in the US that is distinct from both FDA-approved pharmaceuticals and controlled substances.

Here is what you need to know about its legal framework:

  • Not a controlled substance. TB-500 does not appear on any schedule of the Controlled Substances Act. Possessing, prescribing, or dispensing it is not a criminal matter.
  • Not FDA-approved. TB-500 has not gone through the FDA's New Drug Application process. No company has completed the large-scale human clinical trials required for FDA approval. This means it cannot be marketed as a treatment for any specific disease or condition.
  • Available through compounding. Licensed physicians can prescribe TB-500, and 503A or 503B compounding pharmacies can prepare it for individual patients. This is the legal and medically supervised pathway for obtaining the peptide.

The Compounding Pharmacy Framework

Compounding pharmacies operate under federal and state regulations that allow them to prepare customized medications, including peptides, when a physician determines a patient needs a formulation not commercially available as an FDA-approved product.

There are two types of compounding pharmacies relevant to peptide therapy:

  • 503A pharmacies compound medications based on individual patient prescriptions. They are regulated primarily by state boards of pharmacy.
  • 503B outsourcing facilities can produce larger batches without patient-specific prescriptions and operate under direct FDA oversight, including regular inspections and current good manufacturing practice (cGMP) standards.

Both types conduct purity and potency testing, though 503B facilities generally face more stringent quality requirements. Peptides from either source are legal when prescribed appropriately.

Where TB-500 Enters a Gray Area

The legal complexity around TB-500 arises in a few specific contexts:

Research chemical sales. TB-500 is widely sold online as a "research chemical" labeled "not for human consumption." Purchasing peptides through these channels is technically legal in most jurisdictions, but using them for self-administration without a prescription exists in an unregulated space. There are no quality guarantees, and the buyer assumes all risk regarding purity, potency, and sterility.

Competitive sports. The World Anti-Doping Agency (WADA) has specifically prohibited Thymosin Beta-4 under its list of banned substances in the category of peptide hormones, growth factors, and related substances. Athletes subject to WADA testing or national anti-doping agency oversight cannot use TB-500 without risking a positive test and sanctions. This applies to NCAA, Olympic, professional, and many amateur sport organizations.

Veterinary use. TB-500 has been used extensively in equine and veterinary medicine, particularly in horse racing. Several racing jurisdictions have banned its use in competition animals. The regulatory history in horse racing actually predates much of the human interest in the peptide.

What the Research Shows

TB-500's legal availability through compounding is supported by a body of preclinical research. Thymosin Beta-4, the parent molecule, has been studied for its role in cell migration, wound healing, and anti-inflammatory activity.

Published research includes:

  • Acceleration of dermal wound healing in animal models (Annals of the New York Academy of Sciences, 2010)
  • Cardiac tissue repair following myocardial infarction in mice (Journal of Molecular and Cellular Cardiology, 2004)
  • Reduction of inflammation and promotion of tissue remodeling in corneal injury models (Investigative Ophthalmology and Visual Science, 2007)

RegeneRx Biopharmaceuticals conducted Phase II clinical trials on a topical Thymosin Beta-4 formulation (RGN-259) for dry eye, representing one of the few human trial programs for this peptide family.

To use TB-500 legally and safely in the US:

  • Obtain a prescription from a licensed physician who has evaluated your health history and determined TB-500 is appropriate.
  • Fill the prescription through a regulated 503A or 503B compounding pharmacy.
  • Keep prescription documentation with your peptide supply, particularly when traveling.
  • If you are a competitive athlete, confirm TB-500 is permitted under your sport's anti-doping rules before use. In most cases, it is not.

Reported side effects under clinical supervision are generally mild, including temporary lethargy, head rush, and injection-site redness. Serious adverse events are rare in published literature.

  • Can I buy TB-500 without a prescription? You can purchase TB-500 labeled as a research chemical from online vendors without a prescription. However, these products are not regulated for human use, are not tested to pharmaceutical standards, and using them for self-injection carries quality and safety risks. The medically responsible pathway is a physician prescription filled by a compounding pharmacy.
  • Is TB-500 banned in sports? Yes, for most organized sports. WADA classifies Thymosin Beta-4 as a prohibited substance. This ban extends to competitions governed by USADA, NCAA, IOC, and most professional leagues. Athletes should assume TB-500 is prohibited unless their sport's governing body explicitly states otherwise.
  • Could TB-500 become a controlled substance? There is no current legislative effort to schedule TB-500 as a controlled substance. However, the FDA continues to evaluate peptides used in compounding, and regulatory changes could affect availability. Working with a physician ensures you stay informed of any regulatory shifts.

FormBlends provides TB-500 through licensed physicians and regulated compounding pharmacies. Every prescription is based on a clinical evaluation, and every patient receives ongoing support throughout their protocol. Start your consultation at FormBlends.com.

Related Articles